Clostridioides Difficile Infection - Cancer Science

Relevant Publications

Insoluble polysaccharides produced in plant cell cultures protect from Clostridioides difficile colitis.

Issue Release: 2024

Rise to the Challenge: Master the Management of Clostridioides difficile Infection.

Issue Release: 2024

Real-world effectiveness of fecal microbiota transplantation for first or second Clostridioides difficile infection.

Issue Release: 2024

Incidence of public health surveillance-reported Clostridioides difficile infections in thirteen countries worldwide: A narrative review.

Issue Release: 2024

Metagenome-assembled genomes (MAGs) suggest an acetate-driven protective role in gut microbiota disrupted by Clostridioides difficile.

Issue Release: 2024

miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go.

Issue Release: 2024

Clostridium septicum manifests a bile salt germinant response mediated by Clostridioides difficile csp gene orthologs.

Issue Release: 2024

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.

Issue Release: 2024

Active surveillance pharmacovigilance for Clostridioides difficile infection and gastrointestinal bleeding: an analytic framework based on case-control studies.

Issue Release: 2024

Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study.

Issue Release: 2024

Is shorter also better in the treatment of Clostridioides difficile infection?

Issue Release: 2024

Identifying Contact Time Required for Secondary Transmission of Clostridioides difficile Infections by Using Real-Time Locating System.

Issue Release: 2024

Clostridioides difficile infection in patients with and without COVID-19 during the pandemic: a retrospective cohort study from a tertiary referral hospital.

Issue Release: 2024

Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH.

Issue Release: 2024

Monoclonal antibody-mediated neutralization of Clostridioides difficile toxin does not diminish induction of the protective innate immune response to infection.

Issue Release: 2024

Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile.

Issue Release: 2024

Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection.

Issue Release: 2024

Diagnosis of urinary tract infections in the hospitalized older adult population in Alberta.

Issue Release: 2024

Toxin genotypes, antibiotic resistance and their correlations in Clostridioides difficile isolated from hospitals in Xi\'an, China.

Issue Release: 2024

Prescription Microbiome Therapeutic for Recurrent Clostridioides difficile Infection: Fecal Microbiota Live-jslm.

Issue Release: 2024

What should one do if they have a family history of cancer?

What Are the Limitations of Biopsies?

How Does it Compare to Other Pain Management Techniques?

What Are Quality Measures in Cancer Care?

Are There Benefits to Maintaining a Healthy Weight?

Who are Cancer Donors?

How to Identify Peer-Reviewed Articles?

How is Clubbing Diagnosed?

How Common are Mouth Sores in Cancer Patients?

What Happens After a Lung-RADS Classification?

Partnered Content Networks

Relevant Topics